𝛼SK or Searchbullish
エコアニマルヘルス - ECOVAXXIN® MSの商業化開始
SUMMARY
- Following the announcement in December 2025 of European Commission marketing authorisation, Eco Animal Health has announced its commercialisation roadmap for deployment of ECOVAXXIN® MS across key European territories in 2026/27.
- The Group notes that it expects sales of ECOVAXXIN® MS to be immediately margin accretive and, from FY28, make a “material contribution to EBITDA”.
- In line with Group estimates, we expect peak ECOVAXXIN®MS revenue of c.£22m1 by 2031.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- エコアニマルヘルス - ECOVAXXIN® MSの商業化開始27 Feb 2026
x